Patient Experience Data

Learn how to collect, analyze, and leverage patient feedback, enhancing care quality and satisfaction.
What you are going to learn

Empower yourself: mastering PED

Throughout this course you will discover the importance of Patient Experience Data in improving health outcomes and quality of care.

  • Learn about different types of PED, including Patient Preference, Patient Reported Outcomes, and Real-World Evidence.
  • Understand the methodology used for collecting both quantitative and qualitative PED
  • Learn about the role of PED in Regulatory Reviews and Clinical Trial Design
  • Understand the importance of Patient Engagement throughout the medical product development process

Self -paced

Take the whole course or select from the topics most relevant to you. 

Beginner - Intermediate 

This training is a valuable resource for patients,  professionals and advocates involved in healthcare decision-making.

Learn from experts

This course was developed through the collaboration of diverse stakeholders, including patient advocates, researchers, clinicians, representatives of HTA bodies, regulatory authorities, and industry professionals.

Detailed Course Contents

Course reviews

It provided a fantastic overview of so many different types of Patient Experience Data. I would highly recommend for anyone intending to design and conduct a survey, collect data or do any advocacy project.
I gained many new skills, mindsets and understandings. High quality and relevant informatie provided by excellent speakers.
This course was hugely valuable and will really help to drive forwards our efforts to advocate on behalf of our community. I felt it covered all the key topics I was hoping it would.
This WECAN Training Program on Patient Experience Data was initiated in 2023 as part of the WECAN Academy.
Funding for the course was administered by the European Patient Advocacy Institute (EPAI) gUG Germany and was obtained from industry and non-industry funders that included Biomarin, Bristol Myers Squibb, Boehringer Ingelheim, Rising Tide Foundation for Clinical Cancer Research, Roche, Servier and Takeda.
The funders had no role in the course development.